Is There Enough Evidence to Avoid Remdesivir Use in Patients with Severe Renal Impairment? A Review of the Pharmacological and Clinical Literature

Is There Enough Evidence to Avoid Remdesivir Use in Patients with Severe Renal Impairment? A Review of the Pharmacological and Clinical Literature

Although patients with severe renal impairment (SRI) typically experience more critical symptoms once infected with novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus-2, this population has often been excluded from randomized controlled trials (RCT) for Coronavirus disease-2019 (COVID-...

Full description

Bibliographic Details
Main Authors: Suresh J. ANTONY, Emily L. HEYDEMANN, Katrina M. BROWN
Format: Article
Language:Turkish
Published: Galenos Yayinevi 2021-12-01
Series:Mediterranean Journal of Infection, Microbes and Antimicrobials
Subjects:
remdesivir
covid-19
severe renal impairment
end stage renal disease
therapeutics
Online Access:http://mjima.org/abstract.php?id=231

Internet

http://mjima.org/abstract.php?id=231

Similar Items